These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7154134)
41. [Toxicological studies on pepleomycin sulfate (NK 631) II. Subacute toxicity of pepleomycin sulfate in rats (author's transl)]. Tsubosaki M; Irie Y; Ito K; Handa J; Ezura H; Kumagai M; Irie Y; Suzuki A; Yamashita T; Miyamoto K; Matsuda A; Konoha N Jpn J Antibiot; 1978 Dec; 31(12):738-65. PubMed ID: 83405 [TBL] [Abstract][Full Text] [Related]
42. Pemphigoid and pemphigus foliaceus successfully treated with topical corticosteroids. Muramatsu T; Iida T; Shirai T J Dermatol; 1996 Oct; 23(10):683-8. PubMed ID: 8973033 [TBL] [Abstract][Full Text] [Related]
43. A study of the comparative efficacy of diflucortolone valerate 0.3% ointment and clobetasol propionate 0.05% ointment. Wendt H; Mugglestone CJ; Wiseman RA Br J Dermatol; 1978 Oct; 99(4):411-6. PubMed ID: 361059 [TBL] [Abstract][Full Text] [Related]
44. Plasma cortisol values after topical application of diflucortolone valerate (0.3%) or clobetasol propionate (0.05%) in psoriatic patients. Keczkes K; Teasdale P; Wiseman RA; Mugglestone CJ Br J Dermatol; 1978 Oct; 99(4):417-20. PubMed ID: 361060 [TBL] [Abstract][Full Text] [Related]
45. [Comparative evaluation of the potencies of external corticoids with various test methods]. Koch EM; Ott R Z Hautkr; 1988 Mar; 63(3):177-83. PubMed ID: 3388923 [TBL] [Abstract][Full Text] [Related]
46. A comparative, multicenter, double blind trial of 0.05% halobetasol propionate ointment and 0.1% betamethasone valerate ointment in the treatment of patients with chronic, localized plaque psoriasis. Blum G; Yawalkar S J Am Acad Dermatol; 1991 Dec; 25(6 Pt 2):1153-6. PubMed ID: 1757607 [TBL] [Abstract][Full Text] [Related]
47. [A 13-week percutaneous toxicity study of prednisolone farnesylate (PNF) gel in beagle dogs with a recovery period of 5 weeks]. Nagashima Y; Hisaoka F; Ide M; Tamura K; Shimura K; Tanaka G; Tanaka H J Toxicol Sci; 1992 Nov; 17 Suppl 3():123-60. PubMed ID: 1293321 [TBL] [Abstract][Full Text] [Related]
48. [Age-dependent differences in the pharmacodynamic effect of topically applied Corticosteroids]. Koch EM; Ott R; Koehler CO Arzneimittelforschung; 1986 Oct; 36(10):1540-4. PubMed ID: 3814215 [TBL] [Abstract][Full Text] [Related]
49. Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam. Woodford R; Barry BW J Pharm Sci; 1977 Jan; 66(1):99-103. PubMed ID: 319219 [TBL] [Abstract][Full Text] [Related]
51. [Chronic toxicity study on netilmicin in rats (author's transl)]. Otaka T; Miyoshi K; Nomura A; Nakayoshi H Jpn J Antibiot; 1982 Feb; 35(2):499-524. PubMed ID: 7087179 [No Abstract] [Full Text] [Related]
52. BETAMETHASONE 17-VALERATE: A CLINICAL TRIAL OF A NEW TOPICAL STEROID. MITCHELL DM; HEANY SH; EAKINS TS J Ir Med Assoc; 1964 Aug; 55():44-5. PubMed ID: 14179702 [No Abstract] [Full Text] [Related]
53. [A "salve contest" with corticosteroid ointments. Pros and cons of the frequently added neomycin e.d]. SIMONS RD Geneeskd Gids; 1963 Apr; 41():130-8. PubMed ID: 13977541 [No Abstract] [Full Text] [Related]
54. [Toxicological studies on pepleomycin sulfate (NK631), IV. Chronic toxicity of pepleomycin sulfate in rats (author's transl)]. Tsubosaki M; Irie Y; Ito K; Handa J; Ezura H; Kumagai M; Irie Y; Suzuki A; Yamashita T; Miyamoto K; Matsuda A; Konoha N Jpn J Antibiot; 1978 Dec; 31(12):803-36. PubMed ID: 83407 [TBL] [Abstract][Full Text] [Related]
55. Diflucortolone valerate (Nerisona): a comparative vasoconstriction test in artificially induced hyperemia of the skin. Reckers R; Wendt H Clin Ther; 1980; 3(3):190-3. PubMed ID: 7459929 [TBL] [Abstract][Full Text] [Related]
56. Assessment of atrophy of human skin caused by corticosteroids using chamber occlusion and suction blister techniques. Somerma S; Lassus A; Salde L Acta Derm Venereol; 1984; 64(1):41-5. PubMed ID: 6203280 [TBL] [Abstract][Full Text] [Related]
57. A double-blind comparison of 0.25% and 0.05% desoxymethasone, 0.1% betamethasone valerate and 1% hydrocortisone creams in the treatment of eczema. Ashton RE; Catterall M; Morley N; Fairris G; Joseph DN J Int Med Res; 1987; 15(3):160-6. PubMed ID: 3301455 [TBL] [Abstract][Full Text] [Related]
58. [Subacute toxicity of aclacinomycin A in rats (author's transl)]. Shirai M; Ohmori K; Hirano S; Iguchi H; Hori S; Sato H Jpn J Antibiot; 1980 Feb; 33(2):151-62. PubMed ID: 6929358 [TBL] [Abstract][Full Text] [Related]
59. 4-Week repeated intravenous dose toxicity study of a new camptothecin anticancer agent CKD-602 in dogs. Kim JC; Shin DH; Park SH; Park SC; Kim YB; Kim HC; Cha SW; Cho KH; Kang BH; Chung MK Food Chem Toxicol; 2005 May; 43(5):699-706. PubMed ID: 15778009 [TBL] [Abstract][Full Text] [Related]
60. Oleoyl-estrone increases adrenal corticosteroid synthesis gene expression in overweight male rats. Romero Mdel M; Vilà R; Fernández-López JA; Esteve M; Alemany M Steroids; 2010 Jan; 75(1):20-6. PubMed ID: 19793540 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]